Burden of smoking on cause-specific mortality: application to the Nurses' Health Study

被引:59
作者
Kenfield, Stacey A. [1 ,2 ,3 ]
Wei, Esther K. [1 ,2 ,4 ]
Rosner, Bernard A. [1 ,2 ,5 ]
Glynn, Robert J. [2 ,5 ,6 ]
Stampfer, Meir J. [1 ,2 ,3 ]
Colditz, Graham A. [7 ]
机构
[1] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[4] SF Coordinating Ctr, Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA
[5] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA
[7] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
COMPETING RISKS; WOMEN; CESSATION; CANCER;
D O I
10.1136/tc.2009.032839
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective The burden of smoking on six causes of death in women was evaluated using various novel modelling approaches. Design A prospective US-based nationwide cohort study. Participants 102 635 women in the Nurses' Health Study followed biennially from 1980 to 2004. Methods The relation between cigarette smoking and cause-specific death was compared using baseline versus biennially updated smoking status. The authors used competing risk survival analysis to formally compare associations of smoking-related variables on risk of death as a result of coronary heart disease (CHD), cerebrovascular diseases, lung cancer, other respiratory diseases, other smoking-caused cancers and other causes. Results The associations of current and former smoking were stronger with most cause-specific mortality when using updated information. The effect of each smoking-related variable differed significantly (p(h) < 0.0001) across some causes of death. For example, risks increased by 5% for death due to other causes up to 37% for lung cancer death for a 5-year earlier age at initiation. Compared with continuing to smoke, former smokers with 5-10 years of cessation had a 25% reduction in risk of dying from other causes of death up to a 61% reduction in risk of dying from CHD and cerebrovascular diseases. Conclusions The risks of smoking and the benefits from quitting are greater than previously reported, when utilising repeated measures of smoking data collected during follow-up, and vary by cause of death. Focused efforts to communicate the benefits of quitting to smokers and to prevent smoking initiation among children and youths should remain top public health priorities to reduce the worldwide mortality burden caused by smoking.
引用
收藏
页码:248 / 254
页数:7
相关论文
共 50 条
  • [41] Serum Beta Carotene and Overall and Cause-Specific Mortality A Prospective Cohort Study
    Huang, Jiaqi
    Weinstein, Stephanie J.
    Yu, Kai
    Mannisto, Satu
    Albanes, Demetrius
    CIRCULATION RESEARCH, 2018, 123 (12) : 1339 - 1349
  • [42] Adult height and all-cause and cause-specific mortality in the Japan Public Health Center- based Prospective Study (JPHC)
    Ihira, Hikaru
    Sawada, Norie
    Iwasaki, Motoki
    Yamaji, Taiki
    Goto, Atsushi
    Noda, Mitsuhiko
    Iso, Hiroyasu
    Tsugane, Shoichiro
    PLOS ONE, 2018, 13 (05):
  • [43] All-cause and cause-specific mortality after hip fracture among Chinese women and menThe Singapore Chinese Health Study
    G. C.-H. Koh
    B. C. Tai
    L.-W. Ang
    D. Heng
    J.-M. Yuan
    W.-P. Koh
    Osteoporosis International, 2013, 24 : 1981 - 1989
  • [44] All-cause and cause-specific mortality after hip fracture among Chinese women and men The Singapore Chinese Health Study
    Koh, G. C. -H.
    Tai, B. C.
    Ang, L. -W.
    Heng, D.
    Yuan, J. -M.
    Koh, W. -P.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (07) : 1981 - 1989
  • [45] Habitual dietary intake of flavonoids and all-cause and cause-specific mortality: Golestan cohort study
    Jalal Hejazi
    Matin Ghanavati
    Ehsan Hejazi
    Hossein Poustchi
    Sadaf G. Sepanlou
    Masoud Khoshnia
    Abdolsamad Gharavi
    Amir Ali Sohrabpour
    Masoud Sotoudeh
    Sanford M. Dawsey
    Paolo Boffetta
    Christian C. Abnet
    Farin Kamangar
    Arash Etemadi
    Akram Pourshams
    Akbar FazeltabarMalekshah
    Paul Brennan
    Reza Malekzadeh
    Azita Hekmatdoost
    Nutrition Journal, 19
  • [46] Habitual dietary intake of flavonoids and all-cause and cause-specific mortality: Golestan cohort study
    Hejazi, Jalal
    Ghanavati, Matin
    Hejazi, Ehsan
    Poustchi, Hossein
    Sepanlou, Sadaf G.
    Khoshnia, Masoud
    Gharavi, Abdolsamad
    Sohrabpour, Amir Ali
    Sotoudeh, Masoud
    Dawsey, Sanford M.
    Boffetta, Paolo
    Abnet, Christian C.
    Kamangar, Farin
    Etemadi, Arash
    Pourshams, Akram
    FazeltabarMalekshah, Akbar
    Brennan, Paul
    Malekzadeh, Reza
    Hekmatdoost, Azita
    NUTRITION JOURNAL, 2020, 19 (01)
  • [47] Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the Zutphen Elderly Study
    Milder, Ivon E. J.
    Feskens, Edith J. M.
    Arts, Ilja C. W.
    Bueno-de-Mesquita, H. Bas
    Hollman, Peter C. H.
    Kromhout, Daan
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (02) : 400 - 405
  • [48] Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank A Prospective Cohort Study
    Inoue-Choi, Maki
    Ramirez, Yesenia
    Cornelis, Marilyn C.
    de Gonzalez, Amy Berrington
    Freedman, Neal D.
    Loftfield, Erikka
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (09) : 1201 - +
  • [49] A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis
    Johnson, Tate M.
    Yang, Yangyuna
    Roul, Punyasha
    Sauer, Brian C.
    Cannon, Grant W.
    Kunkel, Gary
    Michaud, Kaleb
    Baker, Joshua F.
    Mikuls, Ted R.
    England, Bryant R.
    ARTHRITIS CARE & RESEARCH, 2023, : 1648 - 1658
  • [50] All-cause and cause-specific mortality in microscopic colitis: a Danish nationwide matched cohort study
    Andersen, Nynne Nyboe
    Munck, Lars Kristian
    Hansen, Susanne
    Jess, Tine
    Wildt, Signe
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (02) : 319 - 328